Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs

NCT ID: NCT06641596 Phase: NA Status: COMPLETED Enrollment: 112 Completion: 2024-05-29

Conditions

Overweight, Metabolic Syndrome X

Interventions

Placebo, Cr-400, Cr-800, PE-500, PE-1000

Summary

A randomized, double-blind, placebo controlled, parallel study to determine if Chromium (Cr), Phyllanthus emblica (PE) and Shilajit (SJ) supplementation and Phyllanthus emblica fruit extract supplementation promotes greater changes in glucose homeostasis, endothelial function, and cardiometabolic risk in sedentary and overweight men and women initiating an exercise and weight loss program.

Primary Outcome

Flow-Mediated Dilation (FMD)

Source

ClinicalTrials.gov